We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+6.64%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$13.4B
AUM Growth
+$421M
(+3.2%)
Cap. Flow
-$231M
Cap. Flow
% of AUM
-1.73%
Top 10 Holdings %
Top 10 Hldgs %
18.95%
Holding
286
New
38
Increased
90
Reduced
103
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$95.8M |
| 2 |
Mettler-Toledo International
MTD
|
+$89.4M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$66.9M |
| 4 |
Carnival Corporation Ltd
CCL
|
+$64.4M |
| 5 |
Walt Disney
DIS
|
+$62.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Steris
STE
|
+$102M |
| 2 |
Abbott
ABT
|
+$97.9M |
| 3 |
MGM Resorts International
MGM
|
+$97.5M |
| 4 |
Bank of America
BAC
|
+$90.9M |
| 5 |
Philip Morris
PM
|
+$88.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.01% |
| 2 | Healthcare | 16.54% |
| 3 | Industrials | 13.55% |
| 4 | Financials | 11.42% |
| 5 | Consumer Discretionary | 11.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSE
151
DELISTED
Trinseo
TSE
| $29.3M | 0.22% |
412,930
-13,415
| -3% | -$998K |
|
152
Rockwell Automation
ROK
$49.5B
| $28.6M | 0.21% |
171,923
-902
| -0.5% | -$157K |
|
153
Bright Horizons
BFAM
$3.99B
| $28.4M | 0.21% |
276,978
+9,255
| +3% | +$930K |
|
154
Ascendis Pharma A/S
ASND
$15.9B
| $28.2M | 0.21% |
+424,575
| New | +$27.9M |
|
|
PR
155
Permian Resources
PR
$17.2B
| $27.5M | 0.21% |
+1,520,720
| New | +$27.5M |
|
156
Ironwood Pharmaceuticals
IRWD
$733M
| $26.6M | 0.2% |
+1,662,324
| New | +$24.6M |
|
157
American Eagle Outfitters
AEO
$3.04B
| $26.6M | 0.2% |
1,144,570
-204,305
| -15% | -$4.53M |
|
158
HEICO Corp Class A
HEI.A
$37.1B
| $26.4M | 0.2% |
433,263
+72,763
| +20% | +$4.34M |
|
159
Expedia Group
EXPE
$36.7B
| $26.3M | 0.2% |
219,069
-1,385
| -0.6% | -$160K |
|
160
Texas Roadhouse
TXRH
$13.8B
| $26.1M | 0.2% |
399,018
-27,705
| -6% | -$1.74M |
|
161
H.B. Fuller
FUL
$3.14B
| $26M | 0.19% |
485,040
-110,815
| -19% | -$5.75M |
|
|
RSPP
162
DELISTED
RSP Permian, Inc.
RSPP
| $25.5M | 0.19% |
579,090
-1,097,049
| -65% | -$49.5M |
|
|
CONE
163
DELISTED
CyrusOne Inc Common Stock
CONE
| $25.2M | 0.19% |
432,538
+700
| +0.2% | +$37.9K |
|
164
Dave & Buster's
PLAY
$372M
| $25M | 0.19% |
+525,345
| New | +$23.3M |
|
165
Floor & Decor
FND
$6.5B
| $24.9M | 0.19% |
504,191
+139,676
| +38% | +$7.17M |
|
|
WMGI
166
DELISTED
Wright Medical Group Inc
WMGI
| $24.5M | 0.18% |
942,981
-31,270
| -3% | -$715K |
|
|
KLXI
167
DELISTED
KLX Inc.
KLXI
| $24.2M | 0.18% |
398,708
-738,986
| -65% | -$45.3M |
|
|
VISN
168
Vistance Networks Inc
VISN
$2.8B
| $23.6M | 0.18% |
809,777
+75,857
| +10% | +$2.5M |
|
|
PRTY
169
DELISTED
Party City Holdco Inc.
PRTY
| $23.6M | 0.18% |
1,547,610
+227,550
| +17% | +$3.49M |
|
|
MCRN
170
DELISTED
Milacron Holdings Corp.
MCRN
| $23.6M | 0.18% |
1,245,692
-540,453
| -30% | -$10.7M |
|
171
Guidewire Software
GWRE
$13.4B
| $23.2M | 0.17% |
+261,523
| New | +$23.1M |
|
|
NEWR
172
DELISTED
New Relic, Inc.
NEWR
| $22.9M | 0.17% |
228,114
-188,552
| -45% | -$16.7M |
|
|
SC
173
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $22.8M | 0.17% |
1,196,820
+491,720
| +70% | +$8.97M |
|
174
Old Dominion Freight Line
ODFL
$45.1B
| $22.7M | 0.17% |
458,106
-63,603
| -12% | -$3.16M |
|
175
Omnicell
OMCL
$1.68B
| $22.7M | 0.17% |
433,249
-150,450
| -26% | -$7.08M |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q2 2018 Portfolio in Review
As of Q2 2018, Westfield Capital Management held 286 positions worth $13.4B, up 3.2% from $13B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Westfield Capital Management's Q2 2018 filing shows 38 new, 90 increased, 103 reduced and 43 closed positions. Its largest new stake was Bristol-Myers Squibb: 1,238,227 shares worth $68.5M. The largest sale was Steris, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
- Westfield Capital Management's largest Q2 2018 buy was Bristol-Myers Squibb: 1,238,227 shares worth $68.5M.
- Westfield Capital Management added most to Thermo Fisher Scientific in Q2 2018, an estimated $95.8M increase.
- Westfield Capital Management's biggest Q2 2018 reduction was Steris, cutting an estimated $102M.
- Westfield Capital Management fully exited MGM Resorts International in Q2 2018, selling an estimated $97.5M.
- Westfield Capital Management's ten largest holdings make up 19% of its $13.4B portfolio in Q2 2018.
- Westfield Capital Management opened 38 new positions and closed 43 in Q2 2018.
- Westfield Capital Management's portfolio value rose 3.2% quarter-over-quarter to $13.4B.
Based on Westfield Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.